GILD vs TYL · P/E 18, rev $7.80B vs P/E 89, rev $1.26B
Gilead Sciences Inc (GILD) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the GILD and TYL stock pages for the full models.
Not investment advice.